DERIVES DE TUBULYSINE
- 专利权人:
- R & D BIOPHARMACEUTICALS GMBH
- 发明人:
- RICHTER, WOLFGANG
- 申请号：
- CA2723671
- 公开号：
- CA2723671C
- 申请日:
- 2008.05.09
- 申请国别(地区):
- CA
- 年份:
- 2018
- 代理人:
- 摘要：
- The present invention relates to novel cytotoxic molecules and their use forthe treatment of cancer and otherdiseases.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- SELECTIVE INHIBITORS THROUGH THE INTERACTION OF THE RECEPTOR OF FIBROBLAST GROWTH FACTOR AND FRS2, FOR PREVENTION AND TREATMENT OF CANCER AND OTHER DISEASES
- SELECTIVE INHIBITORS INTERFERING WITH FIBROBLAST GROWTH FACTOR RECEPTOR AND FRS2 INTERACTION FOR THE PREVENTION AND TREATMENT OF CANCER AND OTHER DISEASES
- Selective inhibitors that interfere with the interaction of FRS2 with fibroblast growth factor receptor for the prevention and treatment of cancer
- Tyrosine kinase inhibitors for prevention or treatment of infection
- CELLULAR FACTORS INVOLVED IN THE CYTOTOXICITY OF STAPHYLOCOCCUS AUREUS LEUKOCIDINS: NOVEL THERAPEUTIC TARGETS
